Profile
Dmitry Soloviev is the founder of Cambridge Oncometrix Ltd.
He held the title of Principal Scientist, but is no longer active in that role.
He also held the positions of Founder (FOU) and Chief Technology Officer (CTO) at the company.
Dmitry Soloviev active positions
| Companies | Position | Start |
|---|---|---|
Cambridge Oncometrix Ltd.
 Cambridge Oncometrix Ltd. Medical SpecialtiesHealth Technology Cambridge Oncometrix Ltd. engages in the development of prostate cancer risk stratification test solutions. Its non-invasive pre-biopsy diagnostic test allows for improved prostate cancer risk assessment in primary and secondary care. The company was founded by Maxim Rossmann, Dmitry Soloviev, Irina Soltamova Solovyev, and Pavel Shashkov and is headquartered in Norwich, the United Kingdom. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Cambridge Oncometrix Ltd.
Cambridge Oncometrix Ltd. Medical SpecialtiesHealth Technology Cambridge Oncometrix Ltd. engages in the development of prostate cancer risk stratification test solutions. Its non-invasive pre-biopsy diagnostic test allows for improved prostate cancer risk assessment in primary and secondary care. The company was founded by Maxim Rossmann, Dmitry Soloviev, Irina Soltamova Solovyev, and Pavel Shashkov and is headquartered in Norwich, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Dmitry Soloviev
